China SXT Pharmaceuticals Inc

Company Snapshot
No. 178 Taidong Road North
Taizhou, 225300
China
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full Time Employees: 75
Please select from the dropdown
Company Financials

2022
2023
2024
Gross Profit
$1,251,643
$426,271
$553,971
Operating Income
-$5,189,673
-$5,607,509
-$2,515,217
Net Income
-$5,736,095
-$5,934,772
-$3,098,532
2022
Gross Profit
$1,251,643
Operating Income
-$5,189,673
Net Income
-$5,736,095
2023
Gross Profit
$426,271
Operating Income
-$5,607,509
Net Income
-$5,934,772
2024
Gross Profit
$553,971
Operating Income
-$2,515,217
Net Income
-$3,098,532
The above data on China SXT Pharmaceuticals Inc came from annual proxy statements to the SEC. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov
Top Executives
Total Cash info
Equity info
Other info
Total Compensation
Top Executives
Total Compensation
President, Chief Executive Officer and Chairman of the Board
$50,000
$0
$0
$50,000
$50,000
President, Chief Executive Officer and Chairman of the Board
Chief Financial Officer
$50,000
$0
$0
$50,000
$50,000
Chief Financial Officer
China SXT Pharmaceuticals Inc listed the above executives on its annual proxy statement to the SEC for the fiscal year of 2024. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov

The sum of all cash payments made to an individual for services during a given year. It is comprised of yearly Base Pay and Bonuses

To view more detailed proxy data including previous years contact our sales team.

Contact Us

The value of stock and option awards plus long term incentives granted.

To view more detailed proxy data including previous years contact our sales team.

Contact Us

This covers all compensation that don't fit in any of these other standard categories

To view more detailed proxy data including previous years contact our sales team.

Contact Us